| UNITEDHEALTH GROUP INC (UNH) | $447.57B | 2.7% | 31.5× | $379.60B |
| MCKESSON CORP (MCK) | $403.43B | 1.2% | 20.5× | $92.06B |
| CVS HEALTH Corp (CVS) | $402.07B | 0.4% | 45.9× | $133.62B |
| Cencora, Inc. (COR) | $321.33B | 0.5% | 22.7× | $57.69B |
| Cigna Group (CI) | $274.90B | 2.2% | 12.2× | $76.12B |
| CENTENE CORP (CNC) | $174.58B | -3.8% | — | $33.51B |
| HUMANA INC (HUM) | $129.66B | 0.9% | 42.4× | $47.63B |
| JOHNSON & JOHNSON (JNJ) | $94.19B | 28.5% | 30.0× | $624.26B |
| HCA Healthcare, Inc. (HCA) | $75.60B | 9.0% | 14.1× | $91.07B |
| ELI LILLY & Co (LLY) | $65.18B | 31.7% | 43.1× | $1.08T |
| Merck & Co., Inc. (MRK) | $65.01B | 28.1% | 36.5× | $319.99B |
| PFIZER INC (PFE) | $62.58B | 12.4% | 18.6× | $138.61B |
| AbbVie Inc. (ABBV) | $61.16B | 6.9% | 128.0× | $461.26B |
| BRISTOL MYERS SQUIBB CO (BMY) | $48.19B | 14.6% | 16.3× | $118.71B |
| THERMO FISHER SCIENTIFIC INC. (TMO) | $44.56B | 15.0% | 28.7× | $194.52B |
| ABBOTT LABORATORIES (ABT) | $44.33B | 14.7% | 26.7× | $166.17B |
| AMGEN INC (AMGN) | $36.75B | 21.0% | 26.0× | $201.93B |
| Medtronic plc (MDT) | $36.36B | 13.2% | 22.3× | $106.49B |
| GILEAD SCIENCES, INC. (GILD) | $29.44B | 28.9% | 17.9× | $162.98B |
| Medline Inc. (MDLN) | $28.43B | 4.1% | 37.9× | $76.95B |
| STRYKER CORP (SYK) | $25.12B | 12.9% | 37.8× | $125.18B |
| 3M CO (MMM) | $24.95B | 13.0% | 31.0× | $83.68B |
| DANAHER CORP /DE/ (DHR) | $24.57B | 14.7% | 38.3× | $140.09B |
| BECTON DICKINSON & CO (BDX) | $21.84B | 7.7% | 27.6× | $43.56B |
| TENET HEALTHCARE CORP (THC) | $21.31B | 11.1% | 10.7× | $17.76B |
| GE HealthCare Technologies Inc. (GEHC) | $20.63B | 10.1% | 15.7× | $29.82B |
| BOSTON SCIENTIFIC CORP (BSX) | $20.07B | 14.4% | 18.9× | $67.09B |
| Universe Pharmaceuticals INC (UPC) | $17.86B | -20.6% | — | $4.0M |
| UNIVERSAL HEALTH SERVICES INC (UHS) | $17.36B | 8.6% | 6.6× | $9.57B |
| TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | $17.26B | 8.2% | 26.3× | $41.09B |
| IQVIA HOLDINGS INC. (IQV) | $16.31B | 8.3% | 25.7× | $34.55B |
| AECOM (ACM) | $16.14B | 3.5% | 14.1× | $8.71B |
| REGENERON PHARMACEUTICALS, INC. (REGN) | $14.34B | 31.4% | 16.0× | $68.59B |
| Viatris Inc (VTRS) | $14.25B | -24.7% | — | $19.56B |
| LABCORP HOLDINGS INC. (LH) | $13.95B | 6.3% | 25.4× | $23.53B |
| DAVITA INC. (DVA) | $13.64B | 5.5% | 22.6× | $15.08B |
| BrightSpring Health Services, Inc. (BTSG) | $12.91B | 1.5% | 89.6× | $13.55B |
| COMMUNITY HEALTH SYSTEMS INC (CYH) | $12.48B | 4.1% | 1.1× | $549.6M |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | $12.00B | 32.9% | 31.4× | $134.02B |
| BAXTER INTERNATIONAL INC (BAX) | $11.24B | -8.5% | — | $11.70B |
| Booz Allen Hamilton Holding Corp (BAH) | $11.22B | 7.6% | 9.1× | $7.49B |
| QUEST DIAGNOSTICS INC (DGX) | $11.04B | 9.0% | 23.8× | $23.88B |
| Bausch Health Companies Inc. (BHC) | $10.27B | 1.5% | 11.7× | $1.83B |
| INTUITIVE SURGICAL INC (ISRG) | $10.06B | 28.4% | 51.8× | $150.88B |
| BIOGEN INC. (BIIB) | $9.89B | 13.1% | 23.3× | $31.91B |
| Zoetis Inc. (ZTS) | $9.47B | 28.2% | 12.3× | $31.36B |
| ROCKWELL AUTOMATION, INC (ROK) | $8.34B | 10.4% | 49.0× | $52.49B |
| Solventum Corp (SOLV) | $8.32B | 18.7% | 9.5× | $13.50B |
| ICON PLC (ICLR) | $8.25B | 2.8% | 76.2× | $13.26B |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | $8.23B | 8.6% | 23.3× | $17.37B |
| AGILENT TECHNOLOGIES, INC. (A) | $6.95B | 18.8% | 26.2× | $36.91B |
| Avantor, Inc. (AVTR) | $6.55B | -8.1% | — | $7.05B |
| GARTNER INC (IT) | $6.50B | 11.2% | 13.5× | $9.13B |
| Ardent Health, Inc. (ARDT) | $6.32B | 2.1% | 11.4× | $1.54B |
| Organon & Co. (OGN) | $6.22B | 3.0% | 14.6× | $3.56B |
| Edwards Lifesciences Corp (EW) | $6.07B | 17.7% | 51.0× | $54.34B |
| STERIS plc (STE) | $5.94B | 13.2% | 26.9× | $20.79B |
| Encompass Health Corp (EHC) | $5.94B | 9.5% | 18.2× | $10.56B |
| agilon health, inc. (AGL) | $5.93B | -6.6% | — | $1.85B |
| Option Care Health, Inc. (OPCH) | $5.65B | 3.7% | 17.1× | $3.44B |
| SELECT MEDICAL HOLDINGS CORP (SEM) | $5.45B | 2.7% | 15.4× | $2.05B |
| TETRA TECH INC (TTEK) | $5.44B | 4.6% | 18.7× | $8.08B |
| PAYCHEX INC (PAYX) | $5.41B | 30.6% | 21.7× | $37.82B |
| BeOne Medicines Ltd. (ONC) | $5.34B | 5.4% | 67.5× | $30.88B |
| PACS Group, Inc. (PACS) | $5.29B | 3.6% | 28.7× | $7.04B |
| RESMED INC (RMD) | $5.15B | 27.2% | 20.2× | $30.41B |
| INCYTE CORP (INCY) | $5.14B | 25.0% | 16.5× | $23.35B |
| Bausch & Lomb Corp (BLCO) | $5.10B | -7.1% | — | $6.12B |
| Genpact LTD (G) | $5.08B | 10.9% | 8.9× | $4.93B |
| ENSIGN GROUP, INC (ENSG) | $5.03B | 6.8% | 27.4× | $9.83B |
| Elanco Animal Health Inc (ELAN) | $4.71B | -4.9% | — | $12.55B |
| DEXCOM INC (DXCM) | $4.66B | 17.9% | 30.6× | $27.49B |
| V2X, Inc. (VVX) | $4.48B | 1.7% | 25.9× | $2.22B |
| ILLUMINA, INC. (ILMN) | $4.34B | 19.6% | 35.4× | $29.40B |
| IDEXX LABORATORIES INC /DE (IDXX) | $4.30B | 24.6% | 41.0× | $44.00B |
| Jazz Pharmaceuticals plc (JAZZ) | $4.27B | -8.3% | 2034.8× | $15.34B |
| PERRIGO Co plc (PRGO) | $4.25B | -33.5% | — | $1.53B |
| COOPER COMPANIES, INC. (COO) | $4.09B | 9.2% | 61.5× | $14.16B |
| ALIGN TECHNOLOGY INC (ALGN) | $4.03B | 10.2% | 31.7× | $13.49B |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $4.03B | 21.6% | 30.8× | $26.44B |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | $4.02B | -3.6% | — | $11.15B |
| FTI CONSULTING, INC (FCN) | $3.79B | 7.1% | 18.5× | $4.69B |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | $3.71B | 8.4% | 78.9× | $41.79B |
| DENTSPLY SIRONA Inc. (XRAY) | $3.68B | -16.3% | — | $2.17B |
| TRIMBLE INC. (TRMB) | $3.59B | 11.8% | 27.5× | $12.23B |
| BRUKER CORP (BRKR) | $3.44B | -0.3% | — | $9.34B |
| Acadia Healthcare Company, Inc. (ACHC) | $3.31B | -33.3% | — | $2.86B |
| Surgery Partners, Inc. (SGRY) | $3.31B | -2.4% | — | $2.22B |
| AdaptHealth Corp. (AHCO) | $3.24B | -2.2% | — | $1.40B |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | $3.22B | 10.8% | 42.3× | $11.36B |
| Brookdale Senior Living Inc. (BKD) | $3.19B | -8.2% | — | $3.72B |
| UNITED THERAPEUTICS Corp (UTHR) | $3.18B | 41.9% | 20.2× | $23.13B |
| Astrana Health, Inc. (ASTH) | $3.18B | 0.7% | 76.9× | $2.33B |
| WATERS CORP /DE/ (WAT) | $3.17B | 20.3% | 46.9× | $36.22B |
| MiniMed Group, Inc. (MMED) | $3.10B | -10.7% | — | — |
| WEST PHARMACEUTICAL SERVICES INC (WST) | $3.07B | 16.1% | 47.5× | $25.06B |
| UL Solutions Inc. (ULS) | $3.05B | 10.6% | 57.5× | $20.17B |
| Amneal Pharmaceuticals, Inc. (AMRX) | $3.02B | 2.4% | 45.7× | $5.40B |
| GLOBUS MEDICAL INC (GMED) | $2.94B | 18.3% | 18.8× | $10.93B |
| NEUROCRINE BIOSCIENCES INC (NBIX) | $2.86B | 16.7% | 26.8× | $17.51B |
| REVVITY, INC. (RVTY) | $2.86B | 8.4% | 54.2× | $12.41B |
| QuidelOrtho Corp (QDEL) | $2.73B | -41.5% | — | $1.23B |
| Fortrea Holdings Inc. (FTRE) | $2.72B | -36.2% | — | $1.69B |
| Envista Holdings Corp (NVST) | $2.72B | 1.7% | 67.1× | $4.48B |
| INSULET CORP (PODD) | $2.71B | 9.1% | 36.9× | $10.93B |
| BIO-RAD LABORATORIES, INC. (BIO) | $2.58B | 29.4% | 49.2× | $7.90B |
| Medpace Holdings, Inc. (MEDP) | $2.53B | 17.8% | 35.6× | $16.14B |
| CHEMED CORP (CHE) | $2.53B | 10.5% | 26.2× | $6.38B |
| Teladoc Health, Inc. (TDOC) | $2.53B | -7.9% | — | $1.57B |
| Aveanna Healthcare Holdings, Inc. (AVAH) | $2.43B | 9.2% | 7.9× | $2.08B |
| Royalty Pharma plc (RPRX) | $2.38B | 32.4% | 29.6× | $32.87B |
| Hims & Hers Health, Inc. (HIMS) | $2.35B | 5.5% | 75.1× | $8.86B |
| EXELIXIS, INC. (EXEL) | $2.32B | 33.7% | 18.4× | $13.96B |
| Natera, Inc. (NTRA) | $2.31B | -9.0% | — | $40.64B |
| Enovis CORP (ENOV) | $2.25B | -52.7% | — | $1.49B |
| ICU MEDICAL INC/DE (ICUI) | $2.23B | 0.0% | 85.7× | $3.98B |
| Concentra Group Holdings Parent, Inc. (CON) | $2.16B | 7.7% | 21.4× | $3.81B |
| Privia Health Group, Inc. (PRVA) | $2.12B | 1.1% | 151.4× | $3.24B |
| QIAGEN N.V. (QGEN) | $2.09B | 20.3% | 19.9× | $8.06B |
| RadNet, Inc. (RDNT) | $2.04B | -0.9% | — | $4.85B |
| TELEFLEX INC (TFX) | $1.99B | -45.4% | 2112.7× | $5.61B |
| National Vision Holdings, Inc. (EYE) | $1.99B | 1.5% | 33.4× | $1.52B |
| Moderna, Inc. (MRNA) | $1.94B | -145.2% | — | $31.65B |
| Pediatrix Medical Group, Inc. (MD) | $1.91B | 8.6% | 12.3× | $2.08B |
| Evolent Health, Inc. (EVH) | $1.88B | -28.5% | — | $645.6M |
| MSA Safety Inc (MSA) | $1.87B | 14.9% | 23.5× | $6.74B |
| ICF International, Inc. (ICFI) | $1.87B | 4.9% | 15.7× | $1.32B |
| Sarepta Therapeutics, Inc. (SRPT) | $1.86B | -38.3% | 51.3× | $1.90B |
| Integer Holdings Corp (ITGR) | $1.85B | 5.5% | 23.2× | $3.17B |
| HEALTHCARE SERVICES GROUP INC (HCSG) | $1.84B | 3.2% | 25.9× | $1.69B |
| PTC THERAPEUTICS, INC. (PTCT) | $1.73B | 39.4% | 10.5× | $6.77B |
| Huron Consulting Group Inc. (HURN) | $1.70B | 6.2% | 15.4× | $1.46B |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | $1.64B | -31.6% | — | $1.40B |
| Lantheus Holdings, Inc. (LNTH) | $1.54B | 15.2% | 26.5× | $7.22B |
| MASIMO CORP (MASI) | $1.53B | -9.9% | — | — |
| NATIONAL HEALTHCARE CORP (NHC) | $1.52B | 7.9% | 26.9× | $3.30B |
| MERIT MEDICAL SYSTEMS INC (MMSI) | $1.52B | 8.5% | 29.9× | $4.14B |
| Alkermes plc. (ALKS) | $1.48B | 16.4% | 58.2× | $8.73B |
| P3 Health Partners Inc. (PIII) | $1.46B | -10.1% | — | $2.19B |
| LifeStance Health Group, Inc. (LFST) | $1.42B | 0.7% | 178.5× | $4.09B |
| Addus HomeCare Corp (ADUS) | $1.42B | 6.7% | 18.5× | $1.88B |
| Penumbra Inc (PEN) | $1.40B | 12.7% | 72.9× | $12.42B |
| HALOZYME THERAPEUTICS, INC. (HALO) | $1.40B | 22.7% | 27.5× | $9.28B |
| LivaNova PLC (LIVN) | $1.39B | -17.5% | 42.0× | $4.52B |
| CONMED Corp (CNMD) | $1.37B | 3.4% | 18.5× | $985.5M |
| HAEMONETICS CORP (HAE) | $1.33B | 7.3% | 36.6× | $3.41B |
| PHIBRO ANIMAL HEALTH CORP (PAHC) | $1.30B | 3.7% | 13.5× | $1.27B |
| Progyny, Inc. (PGNY) | $1.29B | 4.5% | 37.4× | $2.26B |
| Curaleaf Holdings, Inc. (CURLF) | $1.27B | -18.2% | — | — |
| Indivior Pharmaceuticals, Inc. (INDV) | $1.24B | 16.9% | 21.0× | $4.85B |
| Nasus Pharma Ltd (NSRX) | $1.24B | -0.5% | — | $41.0M |
| BIO-TECHNE Corp (TECH) | $1.22B | 6.0% | 100.9× | $11.01B |
| Trulieve Cannabis Corp. (TRLV) | $1.18B | -10.3% | — | $1.89B |
| Sotera Health Co (SHC) | $1.16B | 6.7% | 43.3× | $5.06B |
| NOVAVAX INC (NVAX) | $1.12B | 39.2% | 3.7× | $1.55B |
| VSE CORP (VSEC) | $1.11B | 1.1% | 79.4× | $6.42B |
| Prestige Consumer Healthcare Inc. (PBH) | $1.09B | 17.5% | 12.1× | $2.24B |
| Embecta Corp. (EMBC) | $1.08B | 8.8% | 1.7× | $193.4M |
| ACADIA PHARMACEUTICALS INC (ACAD) | $1.07B | 36.5% | 11.4× | $4.32B |
| TANDEM DIABETES CARE INC (TNDM) | $1.01B | -20.2% | — | $1.08B |
| ONTO INNOVATION INC. (ONTO) | $1.01B | 13.6% | 162.7× | $17.48B |
| Guardant Health, Inc. (GH) | $982.0M | -42.4% | — | $22.64B |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | $958.4M | -30.1% | — | $11.86B |
| Pennant Group, Inc. (PNTG) | $947.7M | 3.1% | 43.4× | $1.30B |
| IONIS PHARMACEUTICALS INC (IONS) | $943.7M | -40.4% | — | $13.09B |
| Mirion Technologies, Inc. (MIR) | $925.4M | 3.1% | 179.1× | $4.38B |
| USANA HEALTH SCIENCES INC (USNA) | $925.3M | 1.2% | 43.4× | $401.0M |
| Inspire Medical Systems, Inc. (INSP) | $912.0M | 15.9% | 10.3× | $1.31B |
| NEOGEN CORP (NEOG) | $894.7M | -122.1% | — | $2.03B |
| ANI PHARMACEUTICALS INC (ANIP) | $883.4M | 8.9% | 21.2× | $1.89B |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | $874.8M | 30.2% | 8.0× | $2.45B |
| Warby Parker Inc. (WRBY) | $871.9M | 0.2% | 2937.0× | $3.60B |
| Harmony Biosciences Holdings, Inc. (HRMY) | $868.5M | 18.3% | 14.5× | $2.08B |
| InnovAge Holding Corp. (INNV) | $853.7M | -3.6% | — | $1.59B |
| Onterris, Inc. (ONT) | $830.5M | -0.1% | 137.5× | $745.2M |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | $829.4M | -0.2% | — | $11.33B |
| MYRIAD GENETICS INC (MYGN) | $824.5M | -44.4% | — | $566.7M |
| Orthofix Medical Inc. (OFIX) | $822.3M | -11.2% | — | $377.9M |
| Tilray Brands, Inc. (TLRY) | $821.3M | — | — | $546.9M |
| Caris Life Sciences, Inc. (CAI) | $812.0M | -8.4% | — | $5.30B |
| U S PHYSICAL THERAPY INC /NV (USPH) | $781.0M | 5.1% | 142.6× | $1.09B |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | $780.6M | 8.1% | 17.4× | $1.16B |
| Alphatec Holdings, Inc. (ATEC) | $764.2M | -18.8% | — | $1.36B |
| CORCEPT THERAPEUTICS INC (CORT) | $761.4M | 13.1% | 252.8× | $9.50B |
| iRhythm Holdings, Inc. (IRTC) | $747.1M | -6.0% | — | $4.09B |
| Emergent BioSolutions Inc. (EBS) | $742.9M | 7.1% | 8.9× | $427.2M |
| REPLIGEN CORP (RGEN) | $738.3M | 6.6% | 154.4× | $7.84B |
| NEOGENOMICS INC (NEO) | $727.3M | -14.9% | — | $1.95B |
| Pacira BioSciences, Inc. (PCRX) | $726.4M | 1.0% | 192.5× | $984.9M |
| Mistras Group, Inc. (MG) | $724.0M | 2.3% | 24.5× | $545.3M |
| Amphastar Pharmaceuticals, Inc. (AMPH) | $719.9M | 13.6% | 12.1× | $886.3M |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | $719.0M | -5.4% | — | $2.75B |
| AVANOS MEDICAL, INC. (AVNS) | $701.2M | -10.4% | — | $1.15B |
| RMR GROUP INC. (RMR) | $700.3M | 2.5% | 17.0× | $351.1M |
| Willdan Group, Inc. (WLDN) | $681.6M | 7.7% | 21.0× | $1.18B |
| Kiniksa Pharmaceuticals International, plc (KNSA) | $677.6M | 8.7% | 69.1× | $4.84B |
| Ultragenyx Pharmaceutical Inc. (RARE) | $673.0M | -85.4% | — | $3.19B |
| Cresco Labs Inc. (CRLBF) | $655.8M | -20.6% | — | $289.0M |
| NovoCure Ltd (NVCR) | $655.4M | -20.8% | — | $1.83B |
| 10x Genomics, Inc. (TXG) | $642.8M | -6.8% | — | $4.96B |
| Axsome Therapeutics, Inc. (AXSM) | $638.5M | -28.7% | — | $12.38B |
| TG THERAPEUTICS, INC. (TGTX) | $616.3M | 72.6% | 18.7× | $8.19B |
| LakeShore Biopharma Co., Ltd. (LSBCF) | $615.0M | -16.3% | — | — |
| Cadre Holdings, Inc. (CDRE) | $610.3M | 7.2% | 34.1× | $1.22B |
| OPKO HEALTH, INC. (OPK) | $606.9M | -37.2% | — | $1.16B |
| INSMED Inc (INSM) | $606.4M | — | — | $23.19B |
| TransMedics Group, Inc. (TMDX) | $605.5M | 31.4% | 15.5× | $2.34B |
| UFP TECHNOLOGIES INC (UFPT) | $602.8M | 11.3% | 30.6× | $2.08B |
| CATALYST PHARMACEUTICALS, INC. (CPRX) | $589.0M | 36.4% | 18.2× | $3.85B |
| EXPONENT INC (EXPO) | $582.0M | 18.2% | 28.5× | $2.96B |
| Bioventus Inc. (BVS) | $568.1M | 4.0% | 25.6× | $710.0M |
| Organogenesis Holdings Inc. (ORGO) | $564.2M | 6.6% | 15.7× | $303.7M |
| HUTCHMED (China) Ltd (HCM) | $548.5M | 83.3% | 4.1× | $1.85B |
| Burning Rock Biotech Ltd (BNR) | $539.6M | -10.3% | — | — |
| AtriCure, Inc. (ATRC) | $534.5M | -2.1% | — | $1.61B |
| Mirum Pharmaceuticals, Inc. (MIRM) | $521.3M | -4.5% | — | $7.66B |
| VERACYTE, INC. (VCYT) | $517.1M | 12.8% | 52.9× | $4.55B |
| Inotiv, Inc. (NOTVQ) | $513.0M | -13.4% | — | $348,881 |
| ADMA BIOLOGICS, INC. (ADMA) | $510.2M | 28.8% | 13.2× | $2.07B |
| GLAUKOS Corp (GKOS) | $507.4M | -37.0% | — | $8.71B |
| Oncology Institute, Inc. (TOI) | $502.7M | -12.1% | — | $527.9M |
| BridgeBio Pharma, Inc. (BBIO) | $502.1M | -146.0% | — | $15.12B |
| Ascend Wellness Holdings, Inc. (AAWH) | $500.6M | -23.6% | — | $95.6M |
| Travere Therapeutics, Inc. (TVTX) | $490.7M | -5.2% | — | $5.29B |
| Bowman Consulting Group Ltd. (BWMN) | $490.0M | 2.6% | 46.3× | $502.2M |
| NATURES SUNSHINE PRODUCTS INC (NATR) | $480.1M | 4.1% | 19.5× | $377.5M |
| Ayr Wellness Inc. (AYRWF) | $463.6M | -77.5% | — | $1.5M |
| ACCURAY INC (ARAY) | $458.5M | -0.3% | — | $30.3M |
| Zai Lab Ltd (ZLAB) | $457.2M | -38.4% | — | $2.16B |
| Concord Medical Services Holdings Ltd (CCM) | $454.3M | -20.4% | — | — |
| Tarsus Pharmaceuticals, Inc. (TARS) | $451.4M | -14.7% | — | $2.82B |
| ARTIVION, INC. (AORT) | $441.3M | 2.2% | 95.9× | $1.16B |
| GeneDx Holdings Corp. (WGS) | $427.5M | -4.9% | — | $2.00B |
| MIMEDX GROUP, INC. (MDXG) | $418.6M | 11.6% | 19.8× | $588.3M |
| Innoviva, Inc. (INVA) | $411.3M | 65.9% | 3.6× | $1.65B |
| ARDELYX, INC. (ARDX) | $407.3M | -15.1% | — | $1.30B |
| Esperion Therapeutics, Inc. (ESPR) | $403.1M | -5.6% | — | $814.3M |
| Immunocore Holdings plc (IMCR) | $400.0M | -8.9% | — | $1.65B |
| FORRESTER RESEARCH, INC. (FORR) | $396.9M | -30.1% | — | $183.4M |
| Krystal Biotech, Inc. (KRYS) | $389.1M | 52.6% | 50.2× | $11.06B |
| SINOVAC BIOTECH LTD (SVA) | $386.0M | -51.5% | 6.7× | — |
| SONIDA SENIOR LIVING, INC. (SNDA) | $381.1M | -18.6% | — | $2.00B |
| CareDx, Inc. (CDNA) | $379.8M | -5.6% | — | $1.51B |
| Twist Bioscience Corp (TWST) | $376.6M | -20.6% | — | $6.18B |
| Arcutis Biotherapeutics, Inc. (ARQT) | $376.1M | -4.3% | — | $3.23B |
| InMode Ltd. (INMD) | $370.5M | 25.3% | 11.0× | $850.7M |
| MANNKIND CORP (MNKD) | $349.0M | 1.7% | 226.0× | $1.40B |
| CASTLE BIOSCIENCES INC (CSTL) | $344.2M | -7.0% | — | $731.3M |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | $329.5M | 5.8% | 36.0× | $707.1M |
| Fulgent Genetics, Inc. (FLGT) | $322.7M | -18.8% | — | $592.2M |
| DocGo Inc. (DCGO) | $322.2M | -56.6% | — | $54.0M |
| CorMedix Inc. (CRMD) | $311.7M | 52.3% | 4.0× | $686.5M |
| PROCEPT BioRobotics Corp (PRCT) | $308.1M | -31.0% | — | $1.20B |
| HACKETT GROUP, INC. (HCKT) | $305.6M | 4.2% | 20.8× | $273.0M |
| BillionToOne, Inc. (BLLN) | $305.1M | 2.4% | 222.9× | $5.54B |
| SkinHealth Systems Inc. (SKIN) | $300.8M | -3.2% | — | $94.1M |
| Evolus, Inc. (EOLS) | $297.2M | -17.4% | — | $454.4M |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | $296.2M | 8.1% | 7.0× | $712.8M |
| Inogen Inc (INGN) | $295.3M | -7.7% | — | $178.7M |
| RIGEL PHARMACEUTICALS INC (RIGL) | $294.3M | 124.7% | 2.0× | $716.4M |
| ANGIODYNAMICS INC (ANGO) | $292.5M | -11.6% | — | $540.9M |
| Xeris Biopharma Holdings, Inc. (XERS) | $291.8M | 0.2% | 118.3× | $1.43B |
| Aurinia Pharmaceuticals Inc. (AUPH) | $283.1M | 101.5% | 7.2× | $2.01B |
| Adaptive Biotechnologies Corp (ADPT) | $277.0M | -21.5% | — | $3.39B |
| Vericel Corp (VCEL) | $276.3M | 6.0% | 109.3× | $2.40B |
| HARROW, INC. (HROW) | $272.3M | -1.9% | — | $1.59B |
| VIEMED HEALTHCARE, INC. (VMD) | $270.3M | 5.5% | 32.5× | $460.8M |
| Vireo Growth Inc. (VREOF) | $268.8M | -25.3% | — | — |
| LIGAND PHARMACEUTICALS INC (LGND) | $268.1M | 46.4% | 41.7× | $6.40B |
| FRANKLIN COVEY CO (FC) | $267.1M | 1.1% | 145.2× | $245.5M |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | $263.5M | -148.4% | — | $1.92B |
| Jushi Holdings Inc. (JUSHF) | $262.9M | -26.1% | — | $92.9M |
| ARVINAS, INC. (ARVN) | $262.6M | -30.8% | — | $541.3M |
| Omada Health, Inc. (OMDA) | $260.2M | -4.9% | — | $1.33B |
| Schrodinger, Inc. (SDGR) | $255.9M | -40.4% | — | $1.26B |
| Julong Holding Ltd (JLHL) | $252.0M | 10.4% | — | — |
| LEMAITRE VASCULAR INC (LMAT) | $249.6M | 23.1% | 37.8× | $2.35B |
| Arcus Biosciences, Inc. (RCUS) | $247.0M | -142.9% | — | $3.81B |
| TSS, Inc. (TSSI) | $245.7M | 6.2% | 21.6× | $314.7M |
| Information Services Group Inc. (III) | $244.7M | 3.8% | 19.6× | $196.6M |
| Keros Therapeutics, Inc. (KROS) | $244.1M | 35.7% | 4.9× | $222.9M |
| STAAR SURGICAL CO (STAA) | $239.4M | -33.6% | — | $1.38B |
| Vaxart, Inc. (VXRT) | $237.3M | 6.9% | 4.0× | $154.9M |
| ORTHOPEDIATRICS CORP (KIDS) | $236.3M | -16.8% | — | $512.4M |
| Akebia Therapeutics, Inc. (AKBA) | $236.2M | -2.3% | — | $332.6M |
| ANAPTYSBIO, INC (ANAB) | $234.6M | -5.6% | — | $1.88B |
| CERUS CORP (CERS) | $233.8M | -6.7% | — | $633.2M |
| Talkspace, Inc. (TALK) | $228.9M | 3.4% | — | — |
| Lifevantage Corp (LFVN) | $228.5M | 4.3% | — | — |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | $228.4M | 13.6% | 17.2× | $420.4M |
| Axogen, Inc. (AXGN) | $225.2M | -7.0% | — | — |
| IDEAYA Biosciences, Inc. (IDYA) | $218.7M | -52.0% | — | — |
| Vanda Pharmaceuticals Inc. (VNDA) | $216.1M | -102.0% | — | — |
| AMARIN CORP PLC\UK (AMRN) | $213.6M | -18.2% | — | $343.3M |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | $212.7M | -27.7% | — | — |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $211.1M | -24.2% | — | — |
| Cytek Biosciences, Inc. (CTKB) | $201.5M | -33.0% | — | — |
| SI-BONE, Inc. (SIBN) | $200.9M | -9.4% | — | — |
| Strata Critical Medical, Inc. (SRTA) | $197.1M | 21.0% | — | — |
| LifeMD, Inc. (LFMD) | $194.1M | 7.4% | — | — |
| LAKELAND INDUSTRIES INC (LAKE) | $192.6M | -13.1% | — | — |
| biote Corp. (BTMD) | $192.2M | 14.1% | — | — |
| Mastech Digital, Inc. (MHH) | $191.4M | 0.3% | — | — |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | $189.8M | -103.6% | — | — |
| Public Policy Holding Company, Inc. (PPHC) | $186.5M | -20.9% | — | — |
| MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) | $185.7M | -70.4% | — | $2.23B |
| Stoke Therapeutics, Inc. (STOK) | $184.4M | -3.7% | — | — |
| Glass House Brands Inc. (GLAS) | $182.0M | -16.3% | — | — |
| Adaptimmune Therapeutics PLC (ADAPY) | $178.0M | -39.8% | — | — |
| Cryoport, Inc. (CYRX) | $176.2M | 44.4% | — | — |
| Heartflow, Inc. (HTFL) | $176.0M | -66.3% | — | — |
| Phathom Pharmaceuticals, Inc. (PHAT) | $175.1M | -126.3% | — | — |
| SBC Medical Group Holdings Inc (SBC) | $173.6M | 29.4% | — | — |
| Syndax Pharmaceuticals Inc (SNDX) | $172.4M | — | — | — |
| REGENXBIO Inc. (RGNX) | $170.4M | -113.8% | — | — |
| Ginkgo Bioworks Holdings, Inc. (DNA) | $170.2M | — | — | $679.4M |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | $160.0M | — | — | — |
| MARIMED INC. (MRMD) | $159.8M | -9.1% | — | — |
| Liquidia Corp (LQDA) | $158.3M | -43.5% | — | — |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | $154.9M | -13.0% | — | — |
| Airsculpt Technologies, Inc. (AIRS) | $151.8M | -7.7% | — | — |
| MACROGENICS INC (MGNX) | $149.5M | -49.9% | — | — |
| Neuronetics, Inc. (STIM) | $149.2M | -26.1% | — | — |
| ELITE PHARMACEUTICALS INC /NV/ (ELTP) | $148.9M | 30.1% | — | — |
| GRAIL, Inc. (GRAL) | $147.2M | — | — | — |
| Cronos Group Inc. (CRON) | $146.6M | -6.4% | — | — |
| Karyopharm Therapeutics Inc. (KPTI) | $146.1M | -134.2% | — | — |
| InfuSystem Holdings, Inc (INFU) | $143.4M | 4.6% | — | — |
| Beam Therapeutics Inc. (BEAM) | $139.7M | -57.2% | — | $3.58B |
| Quanterix Corp (QTRX) | $138.9M | -77.1% | — | — |
| NRC HEALTH (NRC) | $137.4M | 8.4% | — | — |
| RxSight, Inc. (RXST) | $134.5M | -29.0% | — | — |
| Xtant Medical Holdings, Inc. (XTNT) | $133.9M | 3.7% | — | — |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | $129.9M | -10.5% | — | — |
| Niagen Bioscience, Inc. (NAGE) | $129.4M | 13.4% | — | — |
| LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) | $128.9M | -30.0% | — | — |
| Xencor Inc (XNCR) | $125.6M | -73.2% | — | — |
| Monte Rosa Therapeutics, Inc. (GLUE) | $123.7M | -31.2% | — | — |
| Atara Biotherapeutics, Inc. (ATRA) | $120.8M | 27.1% | — | — |
| Outset Medical, Inc. (OM) | $119.5M | -68.3% | — | — |
| GYRE THERAPEUTICS, INC. (GYRE) | $116.6M | 8.5% | — | — |
| Zhengye Biotechnology Holding Ltd (ZYBT) | $116.4M | -60.0% | — | — |
| ORASURE TECHNOLOGIES INC (OSUR) | $115.0M | -59.8% | — | $299.5M |
| AGENUS INC (AGEN) | $114.2M | -2.7% | — | — |
| ImmunityBio, Inc. (IBRX) | $113.3M | — | — | — |
| Anika Therapeutics, Inc. (ANIK) | $112.8M | -9.6% | — | — |
| GEOSPACE TECHNOLOGIES CORP (GEOS) | $110.8M | -8.8% | — | — |
| UroGen Pharma Ltd. (URGN) | $109.8M | -139.8% | — | — |
| Century Therapeutics, Inc. (IPSC) | $109.2M | -8.8% | — | — |
| MANNATECH INC (MTEX) | $108.0M | -14.1% | — | — |
| Theravance Biopharma, Inc. (TBPH) | $107.5M | 98.5% | — | — |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | $106.5M | 78.2% | — | — |
| Zymeworks Inc. (ZYME) | $106.0M | -76.6% | — | — |
| Owlet, Inc. (OWLT) | $105.7M | -37.5% | — | — |
| Sanara MedTech Inc. (SMTI) | $103.1M | -36.4% | — | — |
| SUTRO BIOPHARMA, INC. (STRO) | $102.5M | — | — | — |
| Beta Bionics, Inc. (BBNX) | $100.3M | -73.0% | — | — |
| NeuroPace Inc (NPCE) | $100.0M | -21.5% | — | — |
| Butterfly Network, Inc. (BFLY) | $97.6M | -79.0% | — | — |
| Independence Power Holdings, Inc. (ITXP) | $97.2M | 70.9% | — | — |
| BIOLIFE SOLUTIONS INC (BLFS) | $96.2M | -4.8% | — | — |
| SIGA TECHNOLOGIES INC (SIGA) | $94.6M | 24.6% | — | — |
| Pulmonx Corp (LUNG) | $90.5M | -59.7% | — | — |
| VASO Corp (VASO) | $89.1M | 1.8% | — | — |
| Ceribell, Inc. (CBLL) | $89.1M | -60.0% | — | — |
| BIODESIX INC (BDSX) | $88.5M | -39.8% | — | — |
| CYTOKINETICS INC (CYTK) | $88.0M | — | — | — |
| HARVARD BIOSCIENCE INC (HBIO) | $86.5M | -65.5% | — | — |
| STANDARD BIOTOOLS INC. (LAB) | $85.3M | -87.8% | — | — |
| DELCATH SYSTEMS, INC. (DCTH) | $85.2M | 3.2% | — | — |
| 4D Molecular Therapeutics, Inc. (FDMT) | $85.2M | — | — | — |
| ARS Pharmaceuticals, Inc. (SPRY) | $84.3M | — | — | — |
| Nurix Therapeutics, Inc. (NRIX) | $84.0M | — | — | — |
| IRADIMED CORP (IRMD) | $83.8M | 26.8% | — | — |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $82.0M | -80.2% | — | — |
| FITLIFE BRANDS, INC. (FTLF) | $81.5M | 7.8% | — | — |
| MeiraGTx Holdings plc (MGTX) | $81.4M | -140.3% | — | — |
| ADC Therapeutics SA (ADCT) | $81.4M | — | — | — |
| TELA Bio, Inc. (TELA) | $80.3M | -48.4% | — | — |
| Eton Pharmaceuticals, Inc. (ETON) | $80.0M | -5.8% | — | — |
| Sight Sciences, Inc. (SGHT) | $77.4M | -49.7% | — | — |
| CytomX Therapeutics, Inc. (CTMX) | $76.2M | -22.8% | — | — |
| Autolus Therapeutics plc (AUTL) | $75.4M | — | — | — |
| AbCellera Biologics Inc. (ABCL) | $75.1M | — | — | — |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | $74.7M | — | — | — |
| COMPUGEN LTD (CGEN) | $72.8M | 48.6% | — | — |
| BICYCLE THERAPEUTICS PLC (BCYC) | $72.6M | — | — | — |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | $72.3M | -8.5% | — | — |
| AVITA Medical, Inc. (RCEL) | $71.6M | -67.8% | — | — |
| Viridian Therapeutics, Inc.\DE (VRDN) | $70.8M | — | — | — |
| EDAP TMS SA (FOCL) | $70.5M | -41.5% | — | — |
| Aeries Technology, Inc. (AERT) | $70.0M | 4.0% | — | — |
| Black Diamond Therapeutics, Inc. (BDTX) | $70.0M | 32.0% | — | — |
| Personalis, Inc. (PSNL) | $69.6M | -116.7% | — | — |
| ROCKWELL MEDICAL, INC. (RMTI) | $69.3M | -7.7% | — | — |
| Vir Biotechnology, Inc. (VIR) | $68.6M | — | — | — |
| Intellia Therapeutics, Inc. (NTLA) | $67.7M | — | — | — |
| Kura Oncology, Inc. (KURA) | $67.5M | — | — | — |
| Spero Therapeutics, Inc. (SPRO) | $66.8M | 12.8% | — | — |
| PRO DEX INC (PDEX) | $66.6M | 13.5% | — | — |
| EXAGEN INC. (XGN) | $66.6M | -30.0% | — | — |
| AYTU BIOPHARMA, INC (AYTU) | $66.4M | -20.4% | — | — |
| ENANTA PHARMACEUTICALS INC (ENTA) | $65.3M | -125.4% | — | — |
| Electromed, Inc. (ELMD) | $64.0M | 11.8% | — | — |
| Fortress Biotech, Inc. (FBIO) | $63.3M | 10.8% | — | — |
| Nuvation Bio Inc. (NUVB) | $62.9M | — | — | — |
| Tango Therapeutics, Inc. (TNGX) | $62.4M | — | — | — |
| Meihua International Medical Technologies Co., Ltd. (MHUAF) | $61.8M | 11.0% | — | — |
| Journey Medical Corp (DERM) | $61.2M | -18.7% | — | — |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | $59.8M | — | — | — |
| ALPHA PRO TECH LTD (APT) | $59.1M | 6.0% | — | — |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | $56.9M | 8.3% | — | — |
| CVRx, Inc. (CVRX) | $56.7M | -94.1% | — | — |
| 908 Devices Inc. (MASS) | $56.2M | 34.7% | — | — |
| NEKTAR THERAPEUTICS (NKTR) | $55.2M | — | — | — |
| INTEGRATED BIOPHARMA INC (INBP) | $54.4M | 1.5% | — | — |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | $54.0M | — | — | — |
| Q32 Bio Inc. (QTTB) | $53.7M | 55.5% | — | — |
| Invivyd, Inc. (IVVD) | $53.4M | -98.2% | — | — |
| Castellum, Inc. (CTM) | $52.9M | -4.5% | — | — |
| Apyx Medical Corp (APYX) | $52.8M | -21.2% | — | — |
| Protalix BioTherapeutics, Inc. (PLX) | $52.7M | -12.5% | — | — |
| IRIDEX CORP (IRIX) | $52.7M | -8.4% | — | — |
| XOMA Royalty Corp (XOMA) | $52.1M | 60.8% | — | — |
| OCULAR THERAPEUTIX, INC (OCUL) | $52.0M | — | — | — |
| LENSAR, Inc. (LNSR) | $51.7M | -66.4% | — | — |
| CARLSMED, INC. (CARL) | $50.5M | -58.7% | — | — |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | $49.8M | -101.1% | — | — |
| Gossamer Bio, Inc. (GOSS) | $48.5M | — | — | — |
| 1847 Holdings LLC (LBRA) | $48.3M | 136.3% | — | — |
| SHOULDER INNOVATIONS, INC. (SI) | $47.3M | -85.3% | — | — |
| Protagonist Therapeutics, Inc (PTGX) | $46.0M | — | — | $8.46B |
| Septerna, Inc. (SEPN) | $46.0M | -106.4% | — | — |
| TriSalus Life Sciences, Inc. (TLSI) | $45.2M | -86.9% | — | — |
| FENNEC PHARMACEUTICALS INC. (FENC) | $44.6M | -21.8% | — | — |
| Aquestive Therapeutics, Inc. (AQST) | $44.5M | — | — | — |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | $44.5M | -6.4% | — | — |
| SANUWAVE Health, Inc. (SNWV) | $44.1M | 26.8% | — | — |
| Xilio Therapeutics, Inc. (XLO) | $43.8M | -80.1% | — | — |
| Wave Life Sciences Ltd. (WVE) | $42.7M | — | — | — |
| SS Innovations International, Inc. (SSII) | $42.5M | -28.5% | — | — |
| Coherus Oncology, Inc. (CHRS) | $42.2M | — | — | — |
| Biofrontera Inc. (BFRI) | $41.7M | -25.3% | — | — |
| KORU Medical Systems, Inc. (KRMD) | $41.1M | -6.4% | — | — |
| MYOMO, INC. (MYO) | $40.9M | -38.1% | — | — |
| Editas Medicine, Inc. (EDIT) | $40.5M | — | — | — |
| Alpha Teknova, Inc. (TKNO) | $40.5M | -42.6% | — | — |
| Voyager Therapeutics, Inc. (VYGR) | $40.4M | — | — | $228.4M |
| SANGAMO THERAPEUTICS, INC (SGMOQ) | $39.6M | — | — | — |
| Kymera Therapeutics, Inc. (KYMR) | $39.2M | — | — | — |
| INTERPACE BIOSCIENCES, INC. (IDXG) | $38.7M | 63.5% | — | — |
| UTAH MEDICAL PRODUCTS INC (UTMD) | $38.5M | 29.3% | — | — |
| RETRACTABLE TECHNOLOGIES INC (RVP) | $38.3M | -32.8% | — | — |
| Cytosorbents Corp (CTSO) | $37.1M | -22.1% | — | — |
| ClearPoint Neuro, Inc. (CLPT) | $37.0M | -69.1% | — | — |
| LFTD PARTNERS INC. (LIFD) | $36.9M | -67.3% | — | — |
| Sunshine Biopharma Inc. (SBFM) | $36.3M | -16.5% | — | — |
| C4 Therapeutics, Inc. (CCCC) | $35.9M | — | — | — |
| Earth Science Tech, Inc. (ETST) | $35.7M | 10.2% | — | — |
| Verrica Pharmaceuticals Inc. (VRCA) | $35.6M | -50.3% | — | — |
| X4 Pharmaceuticals, Inc (XFOR) | $35.1M | — | — | — |
| Leef Brands Inc. (LEEEF) | $34.8M | -50.7% | — | — |
| BIOHARVEST SCIENCES INC. (BHST) | $34.5M | -32.3% | — | — |
| PRECISION BIOSCIENCES INC (DTIL) | $34.3M | -133.4% | — | — |
| RAPID MICRO BIOSYSTEMS, INC. (RPID) | $33.6M | -140.3% | — | — |
| Orchestra BioMed Holdings, Inc. (OBIO) | $33.5M | — | — | — |
| C21 Investments Inc. (CXXIF) | $32.6M | -9.9% | — | — |
| Stereotaxis, Inc. (STXS) | $32.4M | -66.8% | — | — |
| electroCore, Inc. (ECOR) | $32.0M | -43.6% | — | — |
| Zomedica Corp. (ZOMDF) | $32.0M | — | — | — |
| Premier Air Charter Holdings Inc. (PREM) | $31.9M | -12.1% | — | — |
| Sonendo, Inc. (SONX) | $31.7M | -88.4% | — | — |
| CRYO CELL INTERNATIONAL INC (CCEL) | $31.6M | -7.7% | — | — |
| EyePoint, Inc. (EYPT) | $31.4M | — | — | — |
| Verastem, Inc. (VSTM) | $30.9M | — | — | — |
| Foghorn Therapeutics Inc. (FHTX) | $30.9M | — | — | — |
| STRATA Skin Sciences, Inc. (SSKN) | $30.7M | -20.4% | — | — |
| Synergy CHC Corp. (SNYR) | $30.4M | -40.6% | — | — |
| Scilex Holding Co (SCLX) | $30.3M | — | — | — |
| CapForce Inc. (CFOR) | $30.2M | 78.2% | — | — |
| Bionano Genomics, Inc. (BNGO) | $28.5M | -92.6% | — | — |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | $28.1M | -5.5% | — | — |
| IMMUCELL CORP /DE/ (ICCC) | $27.6M | -3.8% | — | — |
| Sensus Healthcare, Inc. (SRTS) | $27.5M | -28.1% | — | — |
| Cue Biopharma, Inc. (CUE) | $27.5M | -96.9% | — | — |
| CISO Global, Inc. (CISO) | $26.6M | -30.3% | — | — |
| Celularity Inc (CELU) | $26.6M | — | — | — |
| Entrada Therapeutics, Inc. (TRDA) | $25.4M | — | — | — |
| Metagenomi Therapeutics, Inc. (MGX) | $25.2M | — | — | — |
| BGM Group Ltd. (BGM) | $25.1M | -5.7% | — | — |
| Precipio, Inc. (PRPO) | $24.2M | -1.5% | — | — |
| CYANOTECH CORP (CYAN) | $24.2M | -13.2% | — | — |
| ALUMIS INC. (ALMS) | $24.1M | — | — | — |
| ACCESS Newswire Inc. (ACCS) | $22.6M | 19.0% | — | — |
| Baird Medical Investment Holdings Ltd (BDMD) | $22.5M | -121.0% | — | — |
| NewAmsterdam Pharma Co N.V. (NAMS) | $22.5M | — | — | — |
| DarioHealth Corp. (DRIO) | $22.4M | — | — | — |
| Lifeward Ltd. (LFWD) | $22.0M | -90.4% | — | — |
| Alector, Inc. (ALEC) | $21.0M | — | — | — |
| MAXCYTE, INC. (MXCT) | $21.0M | — | — | — |
| Charlie's Holdings, Inc. (CHUC) | $20.9M | 21.5% | — | — |
| CASI Pharmaceuticals, Inc. (CASIF) | $20.7M | — | — | — |
| Jin Medical International Ltd. (ZJYL) | $20.7M | 5.8% | — | — |
| SCYNEXIS INC (SCYX) | $20.6M | -41.8% | — | — |
| Evofem Biosciences, Inc. (EVFM) | $20.2M | 1.9% | — | — |
| Spectral AI, Inc. (MDAI) | $19.6M | -38.5% | — | — |
| Sonoma Pharmaceuticals, Inc. (SNOA) | $19.5M | -16.3% | — | — |
| Sol-Gel Technologies Ltd. (SLGL) | $19.4M | -31.6% | — | — |
| PRECISION OPTICS CORPORATION, INC. (POCI) | $19.1M | -30.3% | — | — |
| LENZ Therapeutics, Inc. (LENZ) | $19.1M | — | — | — |
| QT IMAGING HOLDINGS, INC. (QTI) | $18.9M | -111.4% | — | — |
| NEPHROS INC (NEPH) | $18.8M | 6.4% | — | — |
| Bon Natural Life Ltd (BON) | $18.7M | -10.7% | — | — |
| OmniAb, Inc. (OABIW) | $18.7M | — | — | — |
| Marpai, Inc. (MRAI) | $18.1M | -91.5% | — | — |
| Birchtech Corp. (BCHT) | $17.6M | -17.2% | — | — |
| Vivos Therapeutics, Inc. (VVOS) | $17.4M | -121.4% | — | — |
| Pelthos Therapeutics Inc. (PTHS) | $16.8M | — | — | — |
| Seer, Inc. (SEER) | $16.6M | — | — | — |
| FOXO TECHNOLOGIES INC. (FOXO) | $16.4M | -75.9% | — | — |
| Profound Medical Corp. (PROF) | $16.1M | — | — | — |
| uniQure N.V. (QURE) | $16.1M | — | — | — |
| Neuphoria Therapeutics Inc. (NEUP) | $15.6M | -2.4% | — | — |
| Relay Therapeutics, Inc. (RLAY) | $15.4M | — | — | — |
| ALLURION TECHNOLOGIES, INC. (ALUR) | $15.2M | — | — | — |
| VSEE HEALTH, INC. (VSEE) | $14.6M | -100.6% | — | — |
| Lineage Cell Therapeutics, Inc. (LCTX) | $14.6M | — | — | — |
| Opus Genetics, Inc. (IRD) | $14.2M | — | — | — |
| Arbutus Biopharma Corp (ABUS) | $14.1M | — | — | — |
| Pyxis Oncology, Inc. (PYXS) | $13.9M | — | — | — |
| BIOTRICITY INC. (BTCY) | $13.8M | -61.1% | — | — |
| CV Sciences, Inc. (CVSI) | $13.8M | -6.9% | — | — |
| Hyperfine, Inc. (HYPR) | $13.6M | — | — | — |
| CapsoVision, Inc (CV) | $13.6M | — | — | — |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | $13.1M | — | — | — |
| Nano-X Imaging Ltd. (NNOX) | $13.0M | — | — | — |
| Evommune, Inc. (EVMN) | $13.0M | — | — | — |
| Emmaus Life Sciences, Inc. (EMMA) | $12.5M | -60.2% | — | — |
| ELUTIA INC. (ELUT) | $12.3M | — | — | — |
| Prelude Therapeutics Inc (PRLD) | $12.1M | — | — | — |
| ESCALON MEDICAL CORP (ESMC) | $12.0M | 0.9% | — | — |
| Cardiff Lexington Corp (CDIX) | $11.5M | -47.7% | — | — |
| Jaguar Health, Inc. (JAGX) | $11.5M | — | — | — |
| ACORN ENERGY, INC. (ACFN) | $11.5M | 21.9% | — | — |
| LogicMark, Inc. (LGMK) | $11.4M | -65.4% | — | — |
| NEXGEL, INC. (NXGL) | $11.4M | -26.3% | — | — |
| Caribou Biosciences, Inc. (CRBU) | $11.2M | — | — | — |
| RTB Digital, Inc. (RTB) | $11.1M | — | — | — |
| CRESCENT BIOPHARMA, INC. (CBIO) | $10.8M | — | — | — |
| TScan Therapeutics, Inc. (TCRX) | $10.3M | — | — | — |
| Alpha Cognition Inc. (ACOG) | $10.2M | — | — | — |
| Janux Therapeutics, Inc. (JANX) | $10.0M | — | — | — |
| Zenas BioPharma, Inc. (ZBIO) | $10.0M | — | — | — |
| WORK Medical Technology Group LTD (WOK) | $9.8M | -10.9% | — | — |
| Taysha Gene Therapies, Inc. (TSHA) | $9.8M | — | — | — |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | $9.7M | — | — | — |
| CURIS INC (CRIS) | $9.4M | -80.3% | — | — |
| rYojbaba Co., Ltd. (RYOJ) | $9.3M | 1.3% | — | — |
| Aspira Women's Health Inc. (AWHL) | $9.2M | -138.7% | — | — |
| Pharma-Bio Serv, Inc. (PBSV) | $9.0M | -1.1% | — | — |
| Roivant Sciences Ltd. (ROIV) | $8.3M | — | — | — |
| Aclaris Therapeutics, Inc. (ACRS) | $7.8M | — | — | — |
| Adagene Inc. (ADAG) | $7.7M | — | — | — |
| Whitehawk Therapeutics, Inc. (WHWK) | $7.1M | — | — | — |
| Immunome Inc. (IMNM) | $6.9M | — | — | — |
| FATE THERAPEUTICS INC (FATE) | $6.6M | — | — | — |
| KYNTRA BIO, INC. (KYNB) | $6.4M | — | — | — |
| DBV Technologies S.A. (DBVT) | $5.6M | — | — | — |
| SCIENTIFIC INDUSTRIES INC (SCND) | $5.1M | -24.1% | — | — |
| NewGenIvf Group Ltd (NIVF) | $4.7M | — | — | — |
| ProPhase Labs, Inc. (PRPH) | $4.3M | — | — | — |
| CRISPR Therapeutics AG (CRSP) | $3.5M | — | — | $5.92B |
| Surrozen, Inc./DE (SRZN) | $3.5M | — | — | — |
| Cartesian Therapeutics, Inc. (RNAC) | $2.8M | — | — | — |
| CollPlant Biotechnologies Ltd (CLGN) | $2.4M | — | — | — |
| BNB PLUS CORP. (BNBX) | $2.1M | — | — | — |
| Lipocine Inc. (LPCN) | $2.0M | — | — | — |
| Lichen International Ltd (LICN) | $809,000 | — | — | — |
| Silence Therapeutics plc (SLN) | $559,000 | — | — | — |
| Mereo BioPharma Group plc (MREO) | $500,000 | — | — | — |
| Connect Biopharma Holdings Ltd (CNTB) | $64,000 | — | — | — |
| Amylyx Pharmaceuticals, Inc. (AMLX) | $0 | — | — | $2.03B |
| Artiva Biotherapeutics, Inc. (ARTV) | $0 | — | — | — |
| Barinthus Biotherapeutics plc. (BRNS) | $0 | — | — | — |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | $0 | — | — | — |
| Denali Therapeutics Inc. (DNLI) | $0 | — | — | $4.10B |
| Fulcrum Therapeutics, Inc. (FULC) | $0 | — | — | — |
| KIORA PHARMACEUTICALS INC (KPRX) | $0 | — | — | — |
| Lite Strategy, Inc. (LITS) | $0 | — | — | — |
| Revolution Medicines, Inc. (RVMD) | $0 | — | — | — |
| SPRUCE BIOSCIENCES, INC. (SPRB) | $0 | — | — | — |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | $0 | — | — | — |
| Contineum Therapeutics, Inc. (CTNM) | — | — | — | — |
| T3 Defense Inc. (DFNS) | — | — | — | — |
| Equillium, Inc. (EQ) | — | — | — | — |
| Maze Therapeutics, Inc. (MAZE) | — | — | — | — |
| PALVELLA THERAPEUTICS, INC. (PVLA) | — | — | — | — |
| Stablecoin Development Corp (SDEV) | — | — | — | — |
| Tvardi Therapeutics, Inc. (TVRD) | — | — | — | — |
| VERU INC. (VERU) | — | — | — | — |